Last minute

ETF Growth Opportunities in Chinese Biotech  Bloomberg

Bloomberg's Eric Balchunas and Scarlet Fu break down the Loncar China Biopharma ETF (ticker: CHNA) with Brad Loncar, CEO of Loncar Investments.

Regulatory Red Tape Risks Strangling DC Opportunity Scholarship Program  Daily Signal

Each time the program has been reauthorized, new regulations have been added requiring participating schools to conform more to the public school system.

 




Bookmark us
  • Bookmark this page on Digg
  • Bookmark this page on StumbleUpon
  • Bookmark this page on del.icio.us
  • Bookmark this page on Reddit
  • Bookmark this page on Spurl
  • Bookmark this page on ThisNext